Income statement of PolyPeptide Group AG

1 January–31 December

kCHF

Note

2024

2023

 

 

 

 

Financial income

7

16,720

9,238

Service income

 

9,603

8,947

Total income

 

26,323

18,185

 

 

 

 

Personnel expenses

 

-5,767

-6,201

Other operating expenses

 

-2,284

-2,086

Interest expenses third parties

 

-3,003

-1,083

Interest expenses related parties

 

-2,804

-1,179

Other financial expenses

8

-2,689

-12,770

Depreciation on tangible assets

 

-404

-173

Impairment reversal/loss on investments

9

326,400

-234,000

Operating result before taxes (EBT)

 

335,772

-239,307

 

 

 

 

Taxes

 

Net gain/loss for the year

 

335,772

-239,307